Labcorp Holdings Inc. (FRA:N6B)

Germany flag Germany · Delayed Price · Currency is EUR
222.00
-4.00 (-1.77%)
At close: Dec 5, 2025
-1.33%
Market Cap 18.41B
Revenue (ttm) 11.73B
Net Income (ttm) 728.89M
Shares Out n/a
EPS (ttm) 8.68
PE Ratio 25.26
Forward PE 14.98
Dividend 2.57 (1.13%)
Ex-Dividend Date Nov 26, 2025
Volume n/a
Average Volume 0
Open 222.00
Previous Close 226.00
Day's Range 222.00 - 222.00
52-Week Range 183.00 - 248.00
Beta n/a
RSI 42.57
Earnings Date Feb 5, 2026

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target... [Read more]

Industry Medical Laboratories
Founded 1995
Employees 70,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol N6B
Full Company Profile

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD Financial Statements

News

There is no news available yet.